Sumitomo Pharma Market Cap

Sumitomo Pharma has a market cap or net worth of 552.23 billion as of August 14, 2025. Its market cap has increased by 228.60% in one year.

Market Cap

552.23B

Enterprise Value

841.02B

Revenue

416.16B

Ranking

n/a

PE Ratio

29.21

Stock Price

1,349.00

Market Cap Chart

Since January 14, 1992, Sumitomo Pharma's market cap has increased from 205.93B to 552.23B, an increase of 168.17%. That is a compound annual growth rate of 2.98%.

Market Cap History

Date	Market Cap	% Change
Aug 13, 2025	552.23B	146.89%
Dec 30, 2024	223.67B	20.82%
Dec 29, 2023	185.14B	-53.35%
Dec 30, 2022	396.90B	-24.60%
Dec 30, 2021	526.41B	-13.00%
Dec 30, 2020	605.08B	-28.50%
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 30, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Chugai Pharmaceutical	10.17T
Takeda Pharmaceutical Company	6,786.86B
HOYA Corporation	6,776.33B
Daiichi Sankyo Company	6,600.46B
Otsuka Holdings	4,156.92B
Terumo	4,021.73B
Astellas Pharma	2,952.22B
Shionogi &	2,276.70B

Market Cap Rankings